Paul Begovatz1, Lawrence Lechuga1, Monica Cho2, Mallery Olsen2, Rachel McMahon3, David Vail3,4, and Sean Fain1,5,6
1Medical Physics, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States, 2Pediatrics, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States, 3Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United States, 4Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, United States, 5Radiology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States, 6Biomedical Engineering, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States
Synopsis
Fluorine magnetic
resonance imaging (19F-MRI) has been demonstrated as a non-invasive method
to track and quantify immune cells in vivo. However due to the low 19F
spin density of immune cell labeling, these studies have been mostly conducted on
ultra-high field MRI systems, or with small sensitive surface coils at clinical
field strengths. This feasibility study
found that concentrations of perfluoropolyether (PFPE), and phantoms consisting
of fewer than one million PFPE labeled NK cells were reliably detected through 19F-MRI
with the combination of a cartesian 3D fast spin echo imaging sequence, and a dual
tuned 1H/19F torso coil at 3T.
Introduction
Fluorine magnetic
resonance imaging (19F-MRI) has been demonstrated as a non-invasive method
to label, track and quantify T-cells, natural killer cells (NK cells) or genetically
altered chimeric antigen receptor T-cells (CAR T) in vivo, which are
evolving as novel immunotherapy cancer treatments [1-3]. However due to the low
spin density of 19F nuclei obtained through immune cell labeling in
vivo; to date, these studies have been mostly conducted on ultra-high field
(B0≥7T) small animal MRI
systems, or with small sensitive surface coils at clinical field strengths, which
are not ideal for whole body in vivo cellular tracking [1-3]. Therefore,
this pilot study set out to investigate the feasibility of NK cell tracking on a
clinical 3T MRI with a dual tuned 1H/19F torso coil, through
the investigation of 19F labeled NK cell phantoms measurements, which
will lay the groundwork for future in vivo studies in canine osteosarcoma
patients.Methods
All measurements were conducted on a 3.0T Discovery
MR750w MRI scanner (GE Healthcare, Waukesha, WI) with a 8-channel dual tuned 1H/19F
torso coil (MRI Tools, Berlin, Germany) (Figure 1A). Reproducibility phantom
measurements (N=3) were acquired on separate days, with a cartesian 3D fast spin
echo sequence (TR: 750ms, TE: 27.4ms, ETL: 16, FOV: (200 x 200 x 42)mm, Matrix:
128 x 128, resolution: (3 x 1.6 x 1.6)mm, BW: 14.71kHz, NEX: 32, T = 45 min). Agar phantoms (2% by weight, KCL: 30mM) were
made which covered the surfaces of the coil elements, to ensure proper loading
and spacing during phantom measurements (Figure 1B), and a 0.5 ml sample of
pure Perfluoro-15-crown-5 ether (Exfluor, Round Rock, Texas) was used for
manual flip angle calculation. Phantoms used for the feasibility study consisted
of perfluoropolyether (PFPE) phantoms with 25ul, 50ul, 100ul, 200ul of CS-1000
(Celsense Inc, Pittsburgh, PA) homogenously distributed in 1.5 ml agar vials,
and canine NK cell phantoms (#cells: 0.3x106, 0.6x106, 1.2x106,
3x106, 6x106) which were co-cultured with 8.0 mg/ml
CS-1000 for 4-Hrs (Figure 2C). The canine NK cells were pelleted at the bottom
of a 2 ml conical tube by centrifugation and filled with agar as described previously
[3]. Cell viability of 60%, and a labeling efficiency of 3.65x1012 (19Fnuclei/cell)
were assumed from previous results in our lab [2]. Additional agar loading phantoms
were used to position the PFPE phantoms and simulate the loading and spacing of
a typical canine body (Figure 2 D-E). Signal-to-noise of all images was
measured in FIJI [4], as calculated as the mean of the signal over the standard
deviation of the noise.Results
Cartesian 3D fast spin echo 19F-MRI of the
homogenous PFPE phantoms across (N=3) days revealed a increase in SNR corresponding
with total volume of PFPE [25ul: 7.1±0.6 (mean±SD), 50ul: 13.4±2.0, 100ul: 21.8±1.9, 200ul: 31.7±5.2) within the 45-min scan (Figure 2). In
addition to this, the pelleted PFPE labeled NK cell phantoms were reproducibly
detected with a low variation in SNR at a resolution of (1.6x1.6x3.0)mm during
each imaging session (Figure 3). However, either due to phantom construction or
NMR sensitivity, the small point NK cell phantoms were detected with a comparable
SNR across all quantities of PFPE labeled NK cells [0.3x106: 13.3±2.0, 0.6x106: 13.9±3.0, 1.2x106:11.9±4.5, 3x106:16.4±3.4, 6x106:14.1±3.8).Conclusion
This feasibility phantom study found that concentrations
of PFPE were reliably detected with increased SNR through 19F-MRI
with the combination of a cartesian 3D fast spin echo imaging sequence, and a
dual tuned 1H/19F torso coil at 3T. More importantly, phantoms
consisting of fewer than one million PFPE labeled NK cells were also consistently
detected with the dual tuned torso coil at a similar distance and RF-loading to
those expected in an in vivo canine osteosarcoma patient. Nevertheless, these
results show that additional improvements in pulse sequence development, and in
vivo cell quantification need to be investigated, including the investigation of
non-cartesian 3D k-space sampling techniques [5] which should lead to improved
scan efficiency and sensitivity to PFPE labeled NK cells in vivo.Acknowledgements
-
This project used shared facilities
provided in part by the University of Wisconsin, Department of Medical Physics
and the UW-Carbone Comprehensive Cancer Center
-
This project was supported by a
radiological sciences training grant T32 CA009206 fellowship to Dr. Paul
Begovatz
- This project was supported in part by Celsense
- This project was supported by the ongoing collaboration of GE Healthcare with the University of Wisconsin-Madison
References
1. Srinivas M, Heerschap A, Ahrens E.T, et al., 19F MRI for
quantitative in vivo cell tracking. Trends in Biotechnology 2010; 28:363-370.
2. Bouchlaka M, Ludwig K, Gordon J et al.19F-MRI
for monitoring human NK cells in vivo. Oncoimmunology. 2016; 5:e1143996.
3. Ahrens E.T, Helfer B.M, O’Hanlon C et
al. Clinical Cell Therapy Imaging Using a Perfluorocarbon Tracer and
Fluorine-19 MRI. Magn. Reson. Med. 2014; 72:1696-1701.
4. Schindelin, J.;
Arganda-Carreras, I. & Frise, E. et al. (2012), "Fiji: an open-source platform for biological-image analysis",
Nature methods. 2019; 9(7): 676-682
5. Floegel U, Ahrens ET. Fluorine Magnetic Resonance Imaging.
2017 Pan Stanford Publishing Pte. Ltd.